[Some aspects of substantiation of an individual approach to the treatment of primary ischemic stroke].
The article presents assessment of the state of non-specific resistance of an organism by determination of SH-S-S coefficient relation (K(SU-S-S)) of blood and a spinal liquid in the first days of the disease and their change under influence of different medical products. Features of change of K(SU-S-S) level depending on severity of the clinical course of the disease. Peculiarities of reaction of SH-S-S indicator on pharmacological medications objectifies possibility of individual correction of SH-S-S level of patients with primary ischemic stroke.
Tkachenko
O V
OV
Ts'okha
I O
IO
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006418:Heme / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D057285:Precision Medicine; D020521:Stroke / Q000097:blood / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000975:Antioxidants; D006418:Heme; C015646:Actovegin; D008278:Magnesium Sulfate